» Articles » PMID: 9169913

Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 1997 Jun 1
PMID 9169913
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The authors conducted a study to assess the importance of underlying liver cirrhosis in the development of hepatocellular carcinoma (HCC) and the multifactorial etiology of liver cirrhosis in chronic carriers of hepatitis B virus (HBV). Between November 1980 and May 1990, all male hepatitis B surface antigen (HBsAg) carriers who routinely attended a clinic for asymptomatic HBV carriers at the Liver Unit of Chang-Gung Memorial Hospital, Taiwan, were enrolled in the study (n = 1,506). The authors used this cohort to investigate prospectively for liver cirrhosis and HCC at 6-month intervals by means of ultrasonography and clinical assessment. There were 16 incident cases of HCC and 89 cases of liver cirrhosis (78 of whom were detected during follow-up) identified after an average follow-up of 7.1 years. Subclinical liver cirrhosis diagnosed by ultrasonography was significantly associated with the risk for HCC (multivariate-adjusted relative risk (RR) = 11.8, 95% confidence interval (CI) 3.9-35.8). By multivariate analysis, the significant risk factors found for liver cirrhosis in HBsAg carriers were age, hepatitis B e antigen (HBeAg) carrier status, chronic hepatitis manifested by sustained elevated serum aminotransferase levels for > or = 6 months, cigarette smoking, non-A blood types, and low educational levels. Habitual alcohol drinking was not independently related to liver cirrhosis. However, the risk of liver cirrhosis associated with smoking was more striking among drinkers than nondrinkers (> or = 20 cigarettes/day vs. nonsmokers: drinkers, RR = 9.3, 95% CI 1.1-78.8; nondrinkers, RR = 1.85, 95% CI 0.98-3.51), which suggests a possible modification effect of alcohol drinking on the liver cirrhosis risk of cigarette smoking. The authors observed synergistic effects on liver cirrhosis development for cigarette smoking with HBeAg carrier status and chronic hepatitis.

Citing Articles

Focal Liver Lesions other than Hepatocellular Carcinoma in Cirrhosis: Diagnostic Challenges.

Moller K, Safai Zadeh E, Gorg C, Dong Y, Cui X, Lim A J Transl Int Med. 2023; 10(4):308-327.

PMID: 36860624 PMC: 9969567. DOI: 10.2478/jtim-2022-0068.


Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes.

Xing L, Zeng R, Huang K, Xue J, Liu H, Zhao Z Front Pharmacol. 2022; 13:907921.

PMID: 36249820 PMC: 9555080. DOI: 10.3389/fphar.2022.907921.


Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Coffin C, Fung S, Alvarez F, Cooper C, Doucette K, Fournier C Can Liver J. 2022; 1(4):156-217.

PMID: 35992619 PMC: 9202759. DOI: 10.3138/canlivj.2018-0008.


Association of Smoking and E-Cigarette in Chronic Liver Disease: An NHANES Study.

Chakinala R, Dawoodi S, Fabara S, Asad M, Khayyat A, Chandramohan S Gastroenterology Res. 2022; 15(3):113-119.

PMID: 35836707 PMC: 9239491. DOI: 10.14740/gr1490.


Tobacco smoking and solid fuels for cooking and risk of liver cancer: A prospective cohort study of 0.5 million Chinese adults.

Wen Q, Chan K, Shi K, Lv J, Guo Y, Pei P Int J Cancer. 2022; 151(2):181-190.

PMID: 35199334 PMC: 7612779. DOI: 10.1002/ijc.33977.